ES2551029T3 - Alpha-amylase variants - Google Patents

Alpha-amylase variants Download PDF

Info

Publication number
ES2551029T3
ES2551029T3 ES06110159.8T ES06110159T ES2551029T3 ES 2551029 T3 ES2551029 T3 ES 2551029T3 ES 06110159 T ES06110159 T ES 06110159T ES 2551029 T3 ES2551029 T3 ES 2551029T3
Authority
ES
Spain
Prior art keywords
alpha
amylase
mother
termamyl
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06110159.8T
Other languages
Spanish (es)
Inventor
Allan Svendsen
Søren Kjærulff
Henrik Bisgård-Frantzen
Carsten Andersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Application granted granted Critical
Publication of ES2551029T3 publication Critical patent/ES2551029T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

Variante de una alfa-amilasa madre de tipo Termamyl, donde (a) la variante comprende una o varias de las siguientes sustituciones: E376K; S417T; A420Q o R; S356A; o Y358F y además K176R+I201F+ H205N utilizando la numeración en SEC ID nº: 4, donde la alfa-amilasa madre de tipo Termamyl tiene un grado de identidad para SEC ID nº: 4 de al menos 80%, y (b) la variante tiene actividad de alfa-amilasa y además las variantes tienen y una estabilidad aumentada a pH por debajo de 7.0, y/o a concentraciones de calcio por debajo de 1 mM a temperaturas en el rango de 95°C a 160°C relativamente a la alfa-amilasa madre de tipo Termamyl.Variant of a mother alpha-amylase of the Termamyl type, where (a) the variant comprises one or more of the following substitutions: E376K; S417T; A420Q or R; S356A; or Y358F and in addition K176R + I201F + H205N using the numbering in SEQ ID NO: 4, where the mother alpha-amylase of the Termamyl type has an identity degree for SEQ ID NO: 4 of at least 80%, and (b) the variant It has alpha-amylase activity and in addition the variants have and an increased stability at pH below 7.0, and / or calcium concentrations below 1 mM at temperatures in the range of 95 ° C to 160 ° C relative to the alpha Termamyl-type mother amylase.

ES06110159.8T 1998-11-16 1999-11-16 Alpha-amylase variants Expired - Lifetime ES2551029T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801495 1998-11-16
DK149598 1998-11-16

Publications (1)

Publication Number Publication Date
ES2551029T3 true ES2551029T3 (en) 2015-11-13

Family

ID=54398561

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06110159.8T Expired - Lifetime ES2551029T3 (en) 1998-11-16 1999-11-16 Alpha-amylase variants

Country Status (1)

Country Link
ES (1) ES2551029T3 (en)

Similar Documents

Publication Publication Date Title
DE69842027D1 (en) MUTANTS OF ALPHA AMYLASE
DE69316501D1 (en) Proteases for inhibiting and eliminating biofilm
BR0011130A (en) Metalloprotease inhibitors
IL151313A0 (en) Lipase containing pharmaceutical compositions
GT199900203A (en) CELECOXIB COMPOSITIONS.
ES2137222T3 (en) POLULANASE, MICROORGANISMS THAT PRODUCE IT, PROCEDURES FOR THE PREPARATION OF THE SAME AND UTILIZATIONS.
DE69936201D1 (en) ENZYME STABILIZATION BY CATIONIC SURFACE ACTIVE SUBSTANCES
BR9714517A (en) Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising them and processes to inhibit beta-amyloid peptide release and / or its synthesis by using such compounds
ATE242003T1 (en) ENZYMES FOR TREATING DIABETES MELLITUS TYPE I
BR9713465A (en) Cytically substituted amine metallotprotease inhibitors
DK2333099T3 (en) Enzymes with alpha-amylase activity and methods for their use
DK1091975T3 (en) New cyclosporine with improved activity profile
DE50012408D1 (en) POLYURETHANE SOLUTIONS WITH ALKOXYSILANSTRUCTURE UNITS
DE69429167D1 (en) A STABILIZED PHENYLALANINE AMMONIA LYASE
TR200102913T2 (en) Low molecular weight inhibitors of complete proteases.
DE60023660D1 (en) ANTIZYM MODULATORS AND THEIR USE
DK0601154T3 (en) BPC peptides, their preparation and use
ATE376445T1 (en) SYNERGISTIC INHIBITION OF VIRAL REPLICATION BY LONG CHAIN HYDROCARBONS AND NUCLEOSIDE ANALOGUES
ATE307137T1 (en) TEMPERATURE STABLE DNA POLYMERASE FROM THERMOANAEROBACTER THERMOHYDROSULFURICUS
ATE412666T1 (en) COMPOSITIONS AND METHODS FOR MODULATING RSV INFECTIONS AND IMMUNITY
LV10108A (en) Dog Proliferation Inhibitors Pharmaceutical Composition Compound Acquisition Methods Inhibiting Dog Proliferation
ATE264340T1 (en) STABILIZATION OF FREEZE-DRIED CAKE
DE69840637D1 (en) COMPOSITIONS FOR INCREASING THE EFFICIENCY OF VACCINES USING CHEMOKINS
ES2551029T3 (en) Alpha-amylase variants
ES2174481T3 (en) EMPLOYMENT OF SOLUTIONS CONTAINING ENZYMES FOR THE CLEANING OF FERMENTATION OR STORAGE TANKS.